Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
04/2010
04/07/2010EP2172453A1 COMPOUND HAVING 11 ß-HSD1 INHIBITORY ACTIVITY
04/07/2010EP2172447A1 Amide compound
04/07/2010EP2172217A1 Fibrosis inhibitor
04/07/2010EP2172206A1 The method for a sequoyitol-containing extract obtaining from the genus of trifolium, sobyean and ginkgo biloba and use thereof
04/07/2010EP2172205A1 Pharmaceutical Formulation Comprising Lanthanum Compounds
04/07/2010EP2172201A1 Pharmaceutical composition for amelioration of lower urinary tract symptom associated with prostatomegaly
04/07/2010EP2170401A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily
04/07/2010EP2170064A1 6.5-pyrrolopiperidine tachykinin receptor antagonists
04/07/2010CN1973872B Medicine for nourishing Yin, invigorating kidney, strengthening physique and nourishing brain and its prepn
04/07/2010CN1899384B Medicinal composition for treating nephritis and its preparing method and use
04/07/2010CN101690816A Medicinal composition of calcium-containing antagonist, A II receptor antagonist and statins
04/07/2010CN101690799A Medicament for treating and preventing gynecological inflammation
04/07/2010CN101690782A Chinese medicinal preparation
04/07/2010CN101690781A Traditional Chinese medicine composite for treating chronic nephritis
04/07/2010CN101690763A Nutrition type tonification yang-strengthening medicinal liquor
04/07/2010CN101690740A Calculi dissolving agent for treating urologic calculi
04/07/2010CN101690732A Rana chensinensis egg oil health care product and preparation method thereof
04/07/2010CN101690724A Piperazine ferulate enteric preparation and preparation method thereof
04/07/2010CN101011442B Barrenwort extract fat emulsion composition and its preparing process
04/06/2010US7691967 Smart pro-drugs of serine protease inhibitors
04/06/2010US7691883 decreases expression of a Type I collage gene in a tissue to induce a reduction in accumulation of collagen and thereby improves tissue fibrosis
04/06/2010US7691844 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; inner ear disorders, hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure
04/06/2010US7691804 Administering formulation selected from a BAFF-R polypeptide or fragment; a chimeric molecule comprising a BAFF-R polypeptide or fragment fused to heterologous amino acid sequence; anti-BAFF-R antibody for inhibiting B-cell growth
04/06/2010US7691606 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases
04/06/2010US7691566 Compositions and methods for treatment of cancer
04/06/2010CA2475137C New heterocyclic oxime derivatives, their preparation process and the pharmaceutical compositions that contain them
04/06/2010CA2449899C Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
04/06/2010CA2397636C Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
04/01/2010WO2010037050A2 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
04/01/2010WO2010036567A2 Harmine compounds for promoting bone growth
04/01/2010WO2010035806A1 Solid pharmaceutical composition
04/01/2010WO2010035769A1 Improved antibody molecule
04/01/2010WO2010035745A1 Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
04/01/2010WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same
04/01/2010WO2010035221A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035217A1 Pyrazolo pyridine derivatives as nadph oxidase inhibitors
04/01/2010WO2010035032A1 Calcium ion channel modulators & uses thereof
04/01/2010WO2010034707A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010WO2010034706A1 Substituted purinyl-pyrazol derivatives and their use as potassium channel modulators
04/01/2010WO2010014836A3 Tgr5 modulators and methods of use thereof
04/01/2010WO2010006026A3 Improving renal function with quercetin-containing compositions
04/01/2010WO2008139845A8 Novel amide derivative
04/01/2010US20100081797 Manipulation of Cytokine Levels Using CD83 Gene Products
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100080859 Method for attenuating free radical formation resulting from a bodily insult
04/01/2010CA2738147A1 Solid pharmaceutical composition
03/2010
03/31/2010EP2169060A1 Novel polypeptide useful for diagnosis and treatment of cancer
03/31/2010EP2169038A1 A process for decreasing environmental pollutants in an oil or a fat, and a fish feed product
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168952A1 Morpholine derivative
03/31/2010EP2168579A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
03/31/2010EP2167472A2 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
03/31/2010EP1786814B1 Bicyclononene derivatives as renin inhibitors
03/31/2010EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
03/31/2010EP1244460B1 Use of dipyridinium compounds for treating a disease characterized by proliferating cells containing nitric oxide synthase
03/31/2010CN101687875A Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
03/31/2010CN101687807A 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
03/31/2010CN101687008A Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
03/31/2010CN101686970A Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
03/31/2010CN101686953A Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
03/31/2010CN101684128A Process for preparing glyphosate
03/31/2010CN101684106A Thiazole onium salt compound and application for treating diseases relative to protein aging thereof
03/31/2010CN101684091A cannabinoid receptor ligands
03/31/2010CN101683529A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
03/31/2010CN101683528A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
03/31/2010CN101683523A Preparation method of prostatic cancer specific DC cell vaccine which is insensitive to TGF-belta
03/31/2010CN101683521A Human eryth ropoietin liposome
03/31/2010CN101683496A Asparagus formulation for treating kidney deficiency
03/31/2010CN101683494A Glycyrrhizae radix pulverata prescription for treating nephritis
03/31/2010CN101683489A Folium eriobotryae prescription for treating nephritis
03/31/2010CN101683484A Dodder formulation for treating kidney deficiency
03/31/2010CN101683483A Polygonum multiflorum formulation for treating kidney deficiency
03/31/2010CN101683482A Haricot formulation for treating urinary infection
03/31/2010CN101683481A Kuh-seng formulation for treating nephritic dropsy
03/31/2010CN101683480A Sheep backbone formulation for treating chronic pyelonephritis
03/31/2010CN101683457A Lily prescription for treating nephritis
03/31/2010CN101683451A Formulation of plantain seed leaf for treating urinary infection
03/31/2010CN101683447A White fungus prescription for treating nephritis
03/31/2010CN101683442A Raw rehmanniae formulation for treating urinary infection
03/31/2010CN101683438A Morning glory formulation for treating nephritic dropsy
03/31/2010CN101683415A Bupleurum formulation for treating chronic pyelonephritis
03/31/2010CN101683402A Coptis formulation for treating kidney deficiency
03/31/2010CN101683393A Dandelion formulation for treating urinary infection
03/31/2010CN101683391A Preparation method of pill for removing blood stasis and strengthening kidney
03/31/2010CN101683388A Patch applied on navel for treating enuresis of children and method for producing the same
03/31/2010CN101683384A Desmodium formulation for treating nephritic dropsy
03/31/2010CN101683370A American ginseng prescription for treating nephritis
03/31/2010CN101683317A 缓释组合物 Sustained release composition
03/30/2010US7687606 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil.
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687059 Systems and methods for treating patients with processed lipoaspirate cells
03/30/2010US7687056 containing granulocyte colony-stimulating factor; diabetic nephropathy
03/30/2010CA2472237C Multi-stage oral drug controlled-release system
03/30/2010CA2420894C Thienopyrimidines
03/30/2010CA2176183C 3-substituted oxindole derivatives as potassium channel modulators
03/30/2010CA2155004C Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
03/25/2010WO2010033074A1 Use of a tlr7 agonist for the treatment of cancer
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010032764A1 Therapeutic/prophylactic agent for prostate cancer
03/25/2010WO2010032489A1 Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 562